Vetoquinol (VETO) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.026x

Based on the latest financial reports, Vetoquinol (VETO) has a cash flow conversion efficiency ratio of 0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.72 Million ≈ $17.21 Million USD) by net assets (€567.53 Million ≈ $663.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vetoquinol - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Vetoquinol's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read VETO current and long-term liabilities for a breakdown of total debt and financial obligations.

Vetoquinol Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vetoquinol ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangsu Olive Sensors High-Tech Co Ltd SHE:300507	-0.025x
Fujian Septwolves Industry Co Ltd SHE:002029	0.002x
Asana Inc NYSE:ASAN	0.086x
Service Stream Ltd AU:SSM	0.101x
Lg Electronics Pref KO:066575	0.061x
Shenzhen Sunxing Light Alloys SHG:603978	-0.074x
CareDx Inc NASDAQ:CDNA	0.120x
Rayhoo Motor Dies Co Ltd SHE:002997	0.034x

Annual Cash Flow Conversion Efficiency for Vetoquinol (2004–2024)

The table below shows the annual cash flow conversion efficiency of Vetoquinol from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Vetoquinol stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€575.93 Million ≈ $673.33 Million	€85.83 Million ≈ $100.34 Million	0.149x	-12.13%
2023-12-31	€527.11 Million ≈ $616.25 Million	€89.39 Million ≈ $104.51 Million	0.170x	+30.77%
2022-12-31	€484.66 Million ≈ $566.62 Million	€62.85 Million ≈ $73.48 Million	0.130x	-36.20%
2021-12-31	€441.35 Million ≈ $515.99 Million	€89.72 Million ≈ $104.89 Million	0.203x	-18.05%
2020-12-31	€371.83 Million ≈ $434.71 Million	€92.23 Million ≈ $107.83 Million	0.248x	+84.03%
2019-12-31	€385.98 Million ≈ $451.25 Million	€52.02 Million ≈ $60.82 Million	0.135x	+29.18%
2018-12-31	€363.08 Million ≈ $424.48 Million	€37.88 Million ≈ $44.29 Million	0.104x	-15.03%
2017-12-31	€335.73 Million ≈ $392.50 Million	€41.23 Million ≈ $48.20 Million	0.123x	-10.05%
2016-12-31	€316.48 Million ≈ $369.99 Million	€43.20 Million ≈ $50.51 Million	0.137x	+1.61%
2015-12-31	€289.49 Million ≈ $338.45 Million	€38.90 Million ≈ $45.47 Million	0.134x	-12.68%
2014-12-31	€268.40 Million ≈ $313.78 Million	€41.30 Million ≈ $48.28 Million	0.154x	+29.18%
2013-12-31	€235.96 Million ≈ $275.86 Million	€28.11 Million ≈ $32.86 Million	0.119x	-20.61%
2012-12-31	€228.01 Million ≈ $266.57 Million	€34.21 Million ≈ $39.99 Million	0.150x	+5.70%
2011-12-31	€211.29 Million ≈ $247.02 Million	€29.99 Million ≈ $35.06 Million	0.142x	-23.87%
2010-12-31	€184.27 Million ≈ $215.43 Million	€34.36 Million ≈ $40.17 Million	0.186x	-27.85%
2009-12-31	€154.95 Million ≈ $181.15 Million	€40.05 Million ≈ $46.82 Million	0.258x	+61.72%
2008-12-31	€137.05 Million ≈ $160.23 Million	€21.90 Million ≈ $25.61 Million	0.160x	-45.09%
2007-12-31	€127.87 Million ≈ $149.49 Million	€37.22 Million ≈ $43.51 Million	0.291x	+38.50%
2006-12-31	€111.15 Million ≈ $129.94 Million	€23.36 Million ≈ $27.31 Million	0.210x	-39.22%
2005-12-31	€86.82 Million ≈ $101.50 Million	€30.01 Million ≈ $35.09 Million	0.346x	+19.09%
2004-12-31	€71.38 Million ≈ $83.45 Million	€20.72 Million ≈ $24.23 Million	0.290x	--

About Vetoquinol

PA:VETO France Drug Manufacturers - Specialty & Generic

Market Cap

$1.00 Billion

€856.64 Million EUR

Market Cap Rank

#9162 Global

#145 in France

Share Price

€72.60

Change (1 day)

+0.83%

52-Week Range

€69.20 - €91.00

All Time High

€149.34